United States · FDA National Drug Code directory
nelarabine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81927-111_f21b358e-9f41-4dc3-858f-b55f9a8af715
- Product NDC
- 81927-111
- Form
- INJECTION
- Composition / generic term
- nelarabine
- Labeler
- Shorla Oncology Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230315
- Source listing expiry
- 20261231
Source-listed ingredients
- NELARABINE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-01) / 50 mL in 1 VIAL, SINGLE-DOSE · 81927-111-01
- 6 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-06) / 50 mL in 1 VIAL, SINGLE-DOSE · 81927-111-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →